Drugs / CEA pulsed dendritic cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00154713 | Jul 2005 | colorectal cancer | National Taiwan University Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CEA pulsed dendritic cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00154713 ↗ |
| Modality | Cell therapy | “DC-based cancer immunotherapy” PMID 27558635 ↗ Aug 2016 |
| Route | Subcutaneous | “subcutaneously immunized patients” PMID 27558635 ↗ Aug 2016 |